Latest News

Beyond the Scale: The Surprising Non-Weight Benefits of GLP-1 and GIP Medications

By |2026-08-28T14:50:12+00:00May 3rd, 2017|Sleep Apnea, Weightloss|

When Ozempic and Wegovy first captured public attention, the conversation centered almost entirely on one metric: pounds lost. And the weight loss results were dramatic enough to dominate headlines for years. But researchers, clinicians, and patients have been quietly uncovering something even more significant — these medications appear to be doing far more than shrinking

The Real Cost of GLP-1 Weight Loss Drugs and How to Actually Afford Them

By |2026-08-28T17:49:06+00:00May 3rd, 2017|Diabetes, Obesity, Weightloss|

The headlines are everywhere: a new class of weight loss medications is producing results that doctors haven't seen in decades. But buried beneath the excitement is a question that millions of Americans are confronting every month — can I actually afford this? The short answer is: it depends. The longer answer involves manufacturer coupons, insurance

Mounjaro vs. Zepbound: Same Drug, Different Purpose

By |2026-08-28T15:04:10+00:00May 3rd, 2017|Obesity, Weightloss|

If you've been following the buzz around weight loss medications, you may have noticed two names that keep appearing side by side: Mounjaro and Zepbound. They sound different, they're marketed differently, and they even have different price tags — yet they contain the exact same active ingredient. So what's really going on? Here's the full

Go to Top